Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.

Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.

Abstract: A firearm and tool oiling chamber comprised of an oil less air compressor, sealed chamber, oil atomizer and air filter. Said system introduces air through the oil atomizer breaking oil down to a fine vapor allowing the vapor to cover all surfaces of firearm or tool. As the vapor enters the chamber, being heavier than air it forces air out through the exhaust line and filter. Any escaping oil is caught in filter. The oil is able to cover all surfaces of firearm or tool and to penetrate into areas that hand oiling does not reach using much less oil than conventional methods.

Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.

Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.

Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.

Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method may include a method of treating an infection. The method may comprise administering a microbiota restoration therapy composition to a patient with an infection. The microbiota restoration therapy composition may comprise a mixture of an effective amount of fecal microbiota and an effective amount of polyethylene glycol.

Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method may include a method of treating an infection. The method may comprise administering a microbiota restoration therapy composition to a patient with an infection. The microbiota restoration therapy composition may comprise a mixture of an effective amount of fecal microbiota and an effective amount of polyethylene glycol.

Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.

Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.

Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.

Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.

Abstract: A circuit may include amplifier circuitry configured to receive a current signal at an amplifier input node, convert the current signal to a voltage signal, and output the voltage signal at an amplifier output node. The circuit may also include overload circuitry configured to receive a replica DC input voltage and a replica DC output voltage. The overload circuitry may be further configured to detect that the current signal exceeds a threshold level based on the replica DC input voltage and the replica DC output voltage. In addition, the overload circuitry may be configured to, in response to and based on detecting that the current signal exceeds the threshold level, direct DC current of the current signal through a DC shunt path and direct AC current of the current signal through an AC shunt path. The AC shunt path may be different from the DC shunt path.

Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.

Abstract: A control pad system for a motorcycle has a substantially U-shaped saddle-like unit having a horizontally-disposed upper portion adapted to engage a frame of a motorcycle beneath a seat of the motorcycle, with downward-extending first and second opposite side portions, disposed on each side of the motorcycle frame with the upper portion engaged to the motorcycle frame, and two control pads fashioned from resilient rubber-like material, each having a length, a height and a thickness, one each of the control pads mounted to each of the first and second opposite side portions, such that an outer surface of each control pad is presented outwardly from the motorcycle frame on each side portion. The control pads are positioned in a manner to enable the rider to grip the control pads between the knees, constraining the rider's position forward and rearward on the motorcycle.

Abstract: The present invention relates to a data communication device and method for recording and transmitting data concerning conditions within or pertaining to a transportation container, such as a controlled environment transportation container. The communication device includes a processor, a memory, a port for receiving the data, a first power source, a communication module operatively coupled to the first power source, and a computer program stored in the memory. The program is operative, when executed on the processor, to store the received data in the memory and to cause the communication module to periodically power on, attempt for a specified time period to establish a network connection, and in the event of a successful connection, communicate data stored in the memory over the network, and to power off. The processor independently operates to switch between sleep and active modes in accordance with a system timer or receipt of data, and to determine whether the communication module is to be activated.

Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.

Abstract: A circuit may include amplifier circuitry configured to receive a current signal at an amplifier input node, convert the current signal to a voltage signal, and output the voltage signal at an amplifier output node. The circuit may also include overload circuitry configured to receive a replica DC input voltage and a replica DC output voltage. The overload circuitry may be further configured to detect that the current signal exceeds a threshold level based on the replica DC input voltage and the replica DC output voltage. In addition, the overload circuitry may be configured to, in response to and based on detecting that the current signal exceeds the threshold level, direct DC current of the current signal through a DC shunt path and direct AC current of the current signal through an AC shunt path. The AC shunt path may be different from the DC shunt path.

Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.

Abstract: The invention relates to the monitoring of the state of produce within transport containers, with particular application to dynamic monitoring of the respiration rate of produce in controlled atmosphere container systems used in cargo container transportation.